New Drug Platform
New Drug Development Platform
XANTHO BIO specializes in the chemistry, manufacturing, and controls (CMC) of plant-based new drugs, active ingredients, and Good Agricultural and Collection Practices (GACP).
1
Plant shell
-
Possess exclusive, stable and sufficient supply of the raw materials
-
Plant cultivation in compliance with GACP
-
No safety concerns, long human use experience as herbal medicine
Extraction and Concentration
2
Active Pharmaceutical Ingredients
-
Above 90% of the total components identified
-
Major active components reach above 60% in the API
-
Simple manufacturing steps, CMC easily monitored and controlled
Manufacturing processing
3
Cream
-
Effective in clinical use for treating skin diseases and wound healing
PIPELINE
New Drug Development Progress
Project Name
Project Initiation
Pre-Clinical
IND
Phase I
Phase II
Phase III
Market
GM-XANTHO
Indications：Atopic Dermatitis
2021 Mar
Project Initiation
Pre-Clinical
IND
Phase I
Phase II
Phase III
Market
GM-XAN002
Indications：Pressure Ulcer
2021 Nov
Project Initiation
Pre-Clinical
IND
Phase I
Phase II
Phase III
Market
GM-XAN003
Indications：Plaque Psoriasis
2022 Mar
Project Initiation
Pre-Clinical
IND
Phase I
Phase II
Phase III
Market
GM-XAN005
Indications：Diabetic Wound
2025 Feb
Project Initiation
Pre-Clinical
IND
Phase I
Phase II
Phase III
Market